TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Regulation FD Disclosure
Item 7.01
| 99.01 | Corporate Presentation by the Company for February 2020 (Abbreviated Form) |
Tonix Pharmaceuticals Holding Corp. Exhibit
EX-99.01 2 ex99-01.htm CORPORATE PRESENTATION TONIX PHARMACEUTICALS HOLDING CORP….
To view the full exhibit click here